Δημοσίευση στις Jul 2019 στο PubMed: https://pubmed.ncbi.nlm.nih.gov/31180724/?from_term=tsioufis&from_sort=date&from_size=200&from_pos=31

 

Giuseppe Mancia 

, Kostantinos Tsioufis 

Affiliations

Item in Clipboard

Giuseppe Mancia et al.


Future Cardiol.

Jul 2019

Abstract

The symposium ‘Current perspective on the use of calcium channel blockers in the treatment of hypertensive patients‘, held in Stresa (Italy) on 28th and 29th June 2018 with the participation of the main experts in the field of hypertension from all over the world, reviewed the role of calcium channel blockers in the management of hypertension. Considering the new European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines presented at the last European Society of Hypertension meeting in Barcelona in June 2018, a special attention was focused on lercanidipine. In this article, the main highlights of the symposium were summarized.


Keywords:

calcium channel blocker; hypertension; lercanidipine.

Similar articles

error: